BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs3825942
,
FABP1
,
Angiogenesis
,
Breast Cancer
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tlr9 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Plasmacytoid dendritic cells treated with TLR7 and TLR9 agonists in the presence or absence of RN486
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Macrophage and Monocytes Stimulated By Flagellin
Splenic plasmacytoid dendritic cells (pDC) and conventional dendritic cells (cDC)
B-cells vrom BANK1 KO mice stimulated with CpG OGD
Explore Curated Studies Results
Literature
Most Relevant Literature
Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV.
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development.
Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice.
Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of …
Role of Myeloid Cell-Specific TLR9 in Mitochondrial DNA-Induced Lung Inflammation in Mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer
A Phase I/II Study of Intratumoral Injection of SD-101
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melano…
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resis…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ